Trial Profile
Evaluation of the Interaction of Rimonabant (Antagonist of CB1 Receptor) on the Analgesic Effect of Paracetamol in Intravenous Administration.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Jan 2012
Price :
$35
*
At a glance
- Drugs Rimonabant (Primary) ; Paracetamol
- Indications Pain
- Focus Pharmacodynamics
- 18 Jan 2011 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
- 18 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Sep 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.